Hereditary Insights’ digital platform allows PioneerRx pharmacies to quickly interview Medicare patients and qualify them for a CMS one-time lifetime preventive (no copay, no deductible) Cancer Genomic (CGx) Screening that identifies biomarkers for cancer thus providing patients with hereditary insight and their physicians with the knowledge to construct life-saving clinical protocols. The beneficiary must have Medicare Parts A and B, a diagnosis of cancer (at any time), and there must be at least two additional diagnoses from either side of their family.
Hereditary Insights is pledged to relentless compliance with nationwide regulations (e.g., AKS, False Claims Act, EKRA, Stark) and has developed a platform workflow that qualifies Medicare beneficiaries, and engages your patient's physicians in treatment and results, monitors cheek swab test kit logistics and manages CLIA-certified laboratories. There is no software to buy, no test kits to stock, no items to purchase, and marketing materials are free. Upon contracting, Hereditary Insights provides training and marketing tools while member pharmacies field inquiries (e.g., test status, educational questions, timeline expectations, qualifying criteria), collect new applicant information, and submit applications. For this resource investment, pharmacies are compensated for their time, which is paid, on the last day of the subsequent month of submission.